Protagonist Therapeutics Price Target Raised to $41.00/Share From $30.00 by SVB Leerink
Protagonist Therapeutics Price Target Raised to $41.00/Share From $30.00 by SVB Leerink
DJ Protagonist Therapeutics Is Maintained at Outperform by SVB Leerink
Ratings actions from Benzinga: https://www.benzinga.com/stock/PTGX/ratings
(END) Dow Jones Newswires
March 03, 2021 05:16 ET (10:16 GMT)
DJ Protagonist Therapeutics Price Target Raised to $41.00/Share From $30.00 by SVB Leerink
Ratings actions from Benzinga: https://www.benzinga.com/stock/PTGX/ratings
(END) Dow Jones Newswires
March 03, 2021 05:16 ET (10:16 GMT)
DJ Protagonist Therapeutics Is Maintained at Outperform by SVB Leerink
DJ主角治療公司由SVB Leerink維持在強於大盤的水平
Ratings actions from Benzinga: https://www.benzinga.com/stock/PTGX/ratings
來自本辛加的評級行動:https://www.benzinga.com/stock/PTGX/ratings
(END) Dow Jones Newswires
(完)道瓊通訊社
March 03, 2021 05:16 ET (10:16 GMT)
2021年3月03日05:16美國東部時間(格林尼治標準時間10:16)
DJ Protagonist Therapeutics Price Target Raised to $41.00/Share From $30.00 by SVB Leerink
SVB Leerink將DJ主角治療公司的目標價從每股30.00美元上調至41.00美元
Ratings actions from Benzinga: https://www.benzinga.com/stock/PTGX/ratings
來自本辛加的評級行動:https://www.benzinga.com/stock/PTGX/ratings
(END) Dow Jones Newswires
(完)道瓊通訊社
March 03, 2021 05:16 ET (10:16 GMT)
2021年3月03日05:16美國東部時間(格林尼治標準時間10:16)
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧